Community Acquired Pneumonia Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results

Community acquired pneumonia is a type of pneumonia acquired in extended care facilities. This condition can cause decreased lung function, fever, chest pain, dyspnea, and cough.

Download the sample report @ https://www.pharmaproff.com/request-sample/1057

The sign and symptoms of community acquired pneumonia include chest pain, coughing, fever, shallow breathing, diarrhea, nausea, vomiting, excessive fatigue, hemoptysis, and joint pain. Community acquired pneumonia is generally caused by Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae, Legionella pneumonia, and Chlamydophila pneumoniae.

Get the detailed analysis @ https://www.pharmaproff.com/report/community-acquired-pneumonia-therapeutics-pipeline-analysis

The risk factors associated with this disease include immunodeficiency problems and lung diseases. Biotest AG is in the process of developing immunoglobulin preparation supplemented with immunoglobulin M for the treatment of community acquired pneumonia.

Make enquiry before purchase @ https://www.pharmaproff.com/enquiry/1057

Nabriva Therapeutics plc is also in the process of developing lefamulin as a peptidyltransferase modulator for the treatment of community acquired pneumonia. Some of the companies having the pipeline of community acquired pneumonia include Melinta Therapeutics Inc., and BioAegis Therapeutics Inc. among others.

• The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
• Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

About Us:

Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com

Web: https://www.pharmaproff.com

Connect with us on: LinkedIn | Twitter | Facebook